Kavita Vinod Paul: Transforming Lives Through Comprehensive Care and Community Leadership
Kavita Vinod Paul, National Sales Head at Novo Nordisk, shared a post on LinkedIn:
“I had the opportunity to meet Dr. Maganti BSV Prasad and team, whose unwavering commitment has transformed the lives of thousands of individuals living with hemophilia, thalassemia, sickle cell disease, von Willebrand disease, and other inherited blood disorders.
As the driving force behind the Hemophilia Society, Vijayawada Chapter – Eluru, Dr. Prasad has built far more than a patient support organization – he has created a legacy of compassionate care, early diagnosis, quality diagnostics, patient education, genetic counselling, physiotherapy, psychosocial support, and community empowerment that has touched three generations of patients and families.
What inspired me even more was the Society’s commitment to nurturing future leaders. Under Dr. Prasad’s guidance, the organization has mentored and inspired:
- 1 MD Radiologist
- 4 MBBS students
- 3 IIT graduates
- 3 PhD scholars
- 2 Chartered Accountants
- 3 NIT graduates
- 2 IIIT graduates
- 100 and more IT professionals
- 30 and more professionals serving in Government Services
This extraordinary contribution demonstrates that patient organizations can create an impact far beyond healthcare – empowering individuals, building careers, and inspiring generations of professionals committed to giving back to society.
The Hemophilia Society, Vijayawada Chapter, in collaboration with the Indian Red Cross Society, Eluru District Branch, is a remarkable example of how vision, partnerships, and selfless leadership can improve access to comprehensive care while creating lasting social impact.
My sincere gratitude to Dr. Maganti BSV Prasad and the entire team for their warm hospitality and for reminding us that true leadership is measured not only by the lives we heal but also by the lives we inspire.
Thank you Singa Reddy for the opportunity!”
Stay updated with Hemostasis Today.
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?
-
Sep 22, 2026, 16:20Ila Bappa Ibrahim: Bringing Sickle Cell Innovation Closer to Communities
-
Sep 22, 2026, 16:02Ana Pedrero Gil: Peri-operative Management of Patients Undergoing Day Surgery
-
Sep 22, 2026, 15:27Zia Ullah: RBC-Derived Extracellular Vesicles as Potential Biomarkers of Thrombotic Risk in Dengue
-
Sep 22, 2026, 15:01Lesley Van Wyk: What Each Iron Markers Actually Mean
-
Sep 22, 2026, 14:37Chokri Ben Lamine։ Saudi Arabia Leads A New Milestone In Hemophilia A Care
-
Sep 22, 2026, 13:58Giulia Passaniti: Dual Inferior Vena Cava Anatomy in Tetralogy of Fallot
-
Sep 22, 2026, 13:35Michael Miyamoto: Scaling Guideline Based Lipid Management in Community Practice
-
Sep 22, 2026, 13:15Suvro Sankha Datta: Developing Blood Group Genotyping Platform Using a Gold-Oligo